Pharmacist warns Ozempic and Wegovy users may need blood test
Ozempic and Wegovy users may need blood test, pharmacist warns

Patients taking semaglutide medicines such as Ozempic or Wegovy alongside the blood thinner warfarin may need an INR blood test to check how quickly their blood clots, according to a UK pharmacist. Charlotte Parker-Lennox, a prescribing pharmacist at LloydsPharmacy Online Doctor, said there is no need to be alarmed but advised caution when the two medications are used together.

Why caution is needed with warfarin

Semaglutide is used to manage type 2 diabetes (as Ozempic) or to treat obesity (as Wegovy), and is available only with a prescription through the NHS or privately. Ozempic is not licensed as a weight loss treatment. The NHS website warns that semaglutide may not mix well with some medicines, herbal remedies and supplements, including warfarin, an anticoagulant used to treat and prevent blood clots such as deep vein thrombosis and pulmonary embolism.

Parker-Lennox told the Mirror: “While warfarin and semaglutide are not inherently an unsafe combination, in practice there is caution around their being prescribed together. One reason is that semaglutide slows how quickly food leaves the stomach, which can affect how quickly medicines move through the digestive system.”

INR monitoring advised

She explained that there is no major direct pharmacological interaction between the two medications, but patients taking both should have their blood tested for how quickly it clots – known as an International Normalised Ratio or INR – particularly when starting semaglutide or following a dose increase. She added: “Patients should inform their anticoagulation or warfarin clinic if they are taking semaglutide so that any INR changes can quickly be identified.”

Factors such as weight loss, reduced food intake, nausea, vomiting or changes in dietary intake of vitamin K, which aids clotting, can all influence INR levels. Parker-Lennox reassured that if INR is monitored proactively, the risks associated with using warfarin and semaglutide together are generally low. She urged patients to be alert for signs their blood may be too thin, including blood in the urine, black or tarry stools, frequent or prolonged nosebleeds, and unusual bruising or bleeding.

Follow clinical advice

Ms Parker-Lennox concluded: “Patients should always follow the advice of their prescribing clinician and anticoagulation service regarding INR testing and warfarin dose adjustments.” The NHS also reminds patients to tell a doctor or pharmacist about any other medicines, herbal remedies, vitamins or supplements before using semaglutide.